Simplifying your blood sample analysis with Cell-Free DNA BCT
14 Nov 2023
In this video, Streck provides information on how Cell-Free DNA BCT® can eliminate pre-analytical variation, removing the requirement for immediate plasma isolation. The technology stabilizes cell-free DNA for up to seven days at 6°C to 37°C, featuring a preservative reagent to minimize the release of contaminating cellular genomic DNA during sample handling, shipping, and processing. The stored plasma, including cell-free DNA (cfDNA), remains suitable for use in next-generation sequencing assays cleared or approved for samples collected into Cell-Free DNA BCT.
Related Products
Request Quote for All Products
Cell-Free DNA BCT®
StreckFor In Vitro Diagnostic Use. Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing assays For that have been cleared or approved for use with samples collected into the Cell-Free DNA BCT device. Performance characteristics of this device have only been established on the Guardant360 CDx assay.
